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G
ene regulation by ectopic expres-
sion of key transcription factors
(TFs) not only has high impact in
the field of biomedical research but also
attracts significant research insight in terms
of regulating gene expression.1 By initiating
complex signaling cascades and manipu-
lating genetic circuitry, TFs regulate funda-
mental cellular behaviors and can also over-
ride cellular identity to reprogram and
differentiate cells into specific lineages.2
TFs are master regulators of gene expres-
sion and are structurally composed of mul-
tiple domains, of which three essential
domains are (i) a nuclear localization signal
(NLS) domain to shuttle TFs into the nu-
cleus, (ii) a DNA-binding domain (DBD),
which binds to predefined DNA sequences
in the promoter region of target genes,
and (iii) an activation domain (AD), which
recruits the transcriptional machinery
complex to the binding site to initiate
transcription.
Protein therapy, which involves deliver-
ing proteins into cells to replace dysfunc-
tional proteins, holds immense potential for
applications focusing on regulating gene
expression and cellular behaviors such as
cellular reprogramming, cancer treatment,
and stem cell therapy.3 Numerous ap-
proaches including electroporation, nano-
capsules, lipid micelles, polymer-based
carriers, and nanoparticle-based delivery
have been developed for intracellular pro-
tein delivery.49 However, practical applica-
tion of these methods for gene-regulating
applications is limited because proteins,
especially TFs, that are exogenously intro-
duced into the cells have low delivery effi-
ciency, cannot regulate genetic pathways at
the transcriptional level, lack cell-specific
targeting capabilities, and, above all, are
extremely vulnerable to degradation by
intracellular proteases.10,11
Rather than designing just another pro-
tein delivery vehicle, we sought to develop
an innovative platform that replicates the
fundamental function of TF proteins using a
nanomaterial-based small-molecule approach.
Nanomaterials, such as gold nanoparticles
(AuNPs), have desirable physiochemical as
well as nanostructural properties and have
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ABSTRACT Transcription factor (TF) proteins are master regu-
lators of transcriptional activity and gene expression. TF-based gene
regulation is a promising approach for many biological applications;
however, several limitations hinder the full potential of TFs. Herein,
we developed an artificial, nanoparticle-based transcription factor,
termed NanoScript, which is designed to mimic the structure and function of TFs. NanoScript was constructed by tethering functional peptides and small
molecules called synthetic transcription factors, which mimic the individual TF domains, onto gold nanoparticles. We demonstrate that NanoScript localizes
within the nucleus and initiates transcription of a reporter plasmid by over 15-fold. Moreover, NanoScript can effectively transcribe targeted genes on
endogenous DNA in a nonviral manner. Because NanoScript is a functional replica of TF proteins and a tunable gene-regulating platform, it has great
potential for various stem cell applications.
KEYWORDS: nanoparticle-based genetic manipulation . transcription factor proteins . gene activation .
synthetic transcription factors . nonviral delivery
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been successfully established for biological appli-
cations.12,13 Along with these unique attributes, the
biological inertness and high stability in physiological
conditions make AuNPs excellent carriers of small
molecules and biomolecules.14 Recently, chemical
biologists developed a class of small molecules, called
synthetic transcription factors (STFs), that have been
demonstrated to mimic the function of each TF do-
main, albeit with limited success.1520
Herein, we demonstrate development of a novel
nanoparticle-based artificial transcription factor,
termed NanoScript, which replicates the multidomain
structure and gene-regulating function of natural
TFs (Figure 1a). NanoScript replicates the multidomain
structure of TF proteins because the three major
components, which represent the three major do-
mains (NLS, DBD, and AD) found on endogenous TFs,
are tethered together in close proximity on a single
AuNP (Figure 1b). In addition to serving as a delivery
vehicle for STFs, the AuNP itself serves as a functional
component of the NanoScript because it mimics the
linker domain (LD) of natural TF proteins (Figure 1b).
NanoScript emulates the gene-regulating function of
TFs because the three STF components, which include
(i) a NLS peptide, (ii) a hairpin polyamide DBD, and (iii) a
transactivation peptide AD, all function synergistically
to regulate transcriptional activity of targeted genes in
a nonviral manner (Figure 1c).
The NanoScript platform presented here has several
advantageous features such as a multifunctional AuNP
surface that allows attachment of all STF components
with a flexible density onto a single nanoparticle, a
compact hydrodynamic size (<42 nm diameter) for
effective nuclear localization and DNA intercalation
with intrinsic multivalent interactions, an ability to
target selective predetermined genes, a nonintegra-
tive mechanism for regulating genes, and an inert
AuNP core for maximal stability and biocompatibility
under physiological conditions (Figure 1d). As a result,
our carefully designed NanoScript can localize within
the nucleus and effectively initiate transcriptional ac-
tivity of both a reporter plasmid and endogenous
genes. It is important to note that NanoScript does
not deliver TF proteins but, instead, acts as a functional
platform that is designed to behave like them.
RESULTS AND DISCUSSION
Construction and Characterization of NanoScript. Nano-
Script was synthesized by assembling three essential
components on AuNPs. The first is a hairpin polyamide
Figure 1. Schematic representation of NanoScript's design and function. (a) By assembling individual STF molecules,
including the DBD, AD, and NLS, onto a single 10 nm gold nanoparticle, we have developed the NanoScript platform to
replicate the structure and function of TFs. This NanoScript penetrates the cell membrane and enters the nucleus through the
nuclear receptor with the help of the NLS peptide. Once in the nucleus, NanoScript interacts with DNA to initiate
transcriptional activity and induce gene expression. (b) When comparing the structure of NanoScript to representative TF
proteins, the three essential domains are effectively replicated. The linker domain (LD) fuses the multidomain protein
together and is replicated by the AuNP. (c) The DBD binds to complementary DNA sequences, while the AD recruits
transcriptional machinery components such as RNA polymerase II (RNA Pol II), mediator complex, and general transcription
factors (GTFs). The synergistic function of the DBD and AD moieties on NanoScript initiates transcriptional activity and
expression of targeted genes. (d) The AuNPs are monodisperse and uniform. The NanoScript constructs are shown to
effectively localize within the nucleus, which is important because transcriptional activity occurs only in the nucleus.
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structure (representing the DBD), which was specifi-
cally chosen because of its high specificity to target
DNA sequences and exceptionally high binding affinity
that is comparable to naturally occurring DNA-binding
proteins.21,22 The hairpin polyamide is composed of
N-methylpyrrole (Py) andN-methylimidazole (Im) amino
acids, which bind to complementary A-T and G-C
motifs on the DNA, respectively.23 Using solid-phase
synthesis, a polyamide was synthesized with amino
acids arranged in the order ImPyPyPy-γ-PyPyPyPy-β-
Dp-NH2 (γ is γ-aminobutyric acid, β is β-alanine, and
Dp is dimethylaminopropylamide), to recognize the
50-WGWWWW-30 (W=Aor T) DNA sequence (Figure 2a).
This sequence was specifically chosen to recognize
the matching DNA sequence of our proof-of-concept
reporter plasmid, which will be used to evaluate its
gene-regulating functionality (details described below).
Using surface plasmon resonance, the binding affinity
of the polyamide to its target sequencewas determined
to have a remarkably high nanomolar affinity with an
equilibrium constant of 1.6  109 M (Figure 2b). In
addition, the polyamide binding affinity to a mis-
matched DNA sequence decreased by over 70-fold,
thus implying the polyamide is specific for its target
sequence (Figure S1).
The second component (representing the AD) is a
synthetic transactivation peptide that was synthesized
in the D-form to resist intracellular degradation and is
capable of activating transcriptional activity by recruit-
ing mediators, RNA polymerase II, SAGA, and other
proteins to the binding site.2426 The third component
(representing the NLS domain) is a nuclear loca-
lization signal peptide derived from the SV40 large
T-antigen and functions to shuttle NanoScript into the
nucleus.2729
These three components were then assembled
onto a single nanoparticle using a carefully designed
conjugation chemistry to develop NanoScript. The
NanoScript platform was constructed by first coating
AuNPs with mercaptoundeconic acid (MUA) and then
conjugating the three STF components via EDC/NHS
coupling (Figure 3a). This reaction was carried out in
a controlled buffered (pH = 6.07.4) solution to ensure
conjugation through the primary amine, but there is a
possibility that NLS binds either directly to the AuNP or
through lysine side chains, which should not influence
its functionality.29 Adsorption of the STF components
on the AuNPs was confirmed by UV spectroscopy,
which indicated a successive shift of the surface plas-
mon peak (Figure S2). On the basis of previous reports,
we are confident the DBD conjugated to Nano-
Script binds preferentially to the target sequence.30
In terms of the STF ratio on NanoScript, we speculated
a high ratio of NLS would be required because
translocation of NanoScript into the nucleus is one
of the most critical barriers for effective gene activa-
tion. Furthermore, we anticipated that a minimal ratio
of the polyamide DBD would be required because
of its exceptionally high binding affinity to DNA and
that the ratio of AD be doubled in order to mimic the
potent endogenous TF p53.31 Therefore, we designed
NanoScript to have an optimum ratio of STF com-
ponents and quantified the surface ratio using
high-pressure liquid chromatography (HPLC) analysis
(Table S1).
The physical properties were characterized using
dynamic light scattering, which determined the hydro-
dynamic diameter of NanoScript to be 34.0 ( 2.3 nm
and the surface charge to be32.5mV (Figure 3b). This
hydrodynamic diameter is in excellent agreement with
the theoretical value, because, based on calculating
bond lengths, we predicted the theoretical diameter of
NanoScript to be 35.2 nm. Electron micrographs of
NanoScript confirmed that surface functionalization
with STF components did not affect the size distribu-
tion ormonodispersity of the nanoparticles (Figure 3c).
The stability of both NanoScript and MUA-coated
AuNPs (Au-MUA) was tested in various physiological
environments including water, PBS, and culture media
and showed that the nanoparticles remained stable in
these environments, as indicated by minimal shifts in
the absorbance peak (Figure S3).
Figure 2. The Py-Im hairpin polyamide has high binding
affinity for the target sequence. (a) The hairpin polyamide
structures of the DBD containing pyrrole (Py) and imidazole
(Im) motifs, which bind to A-T and G-C base pairs, respec-
tively, are arranged to target the 30-WWWWGW-50 sequence
(W = A or T). The hairpin polyamide DBD is anchored with a
dimethylaminopropylamine (DMAPA) moiety to enable con-
jugation. (b) SPR sensorgrams show the interaction of vary-
ing polyamide DBD concentrations with complementary
hairpin DNAs. The equilibrium constant (KD), which is indica-
tive of thebindingaffinity,wasdeterminedby the ratio of the
dissociation constant (kd) to the association constant (ka).
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Nuclear Localization of NanoScript. Efficient nuclear lo-
calization of NanoScript is especially important be-
cause transcriptional activity occurs exclusively in the
nucleus. To this end, NanoScript was specifically de-
signedwith a small hydrodynamic diameter (∼34.0 nm
as mentioned above) because the nuclear pore, which
tightly regulates cargo transport across the nuclear
envelope, has a maximum diameter of approximately
44 nm.3234 The plasma membrane permeability of
NanoScript was assessed by first incubating Nano-
Script with HeLa cells for 4 h and then quantifying
the number of particles that were able to enter the cells
using inductively coupled plasma atomic emission
spectroscopy (ICP-OES). Analysis revealed that Nano-
Script was able to efficiently penetrate the plasma
membrane in just 4 h of incubation, as compared to
the control (NanoScript without NLS peptide), which
showed minimal uptake (Figure 4a), which indicates
that the NLS peptide also plays a significant role in
enabling NanoScript to enter the cell. To monitor
intracellular localization, NanoScript was labeled with
a fluorescent dye and incubated in HeLa cell cultures.
Fluorescence images, taken with a 3D structured illu-
mination microscope, shows that NanoScript is able to
target and penetrate the nuclear envelope (Figure 4b,
Figure S4). As indicated by the phase contrast image,
the HeLa cells seem to remain intact (Figure S5).
Additionally, a side-view image indicates that Nano-
Script is evenly dispersed throughout the nucleus in
the vertical plane, thus confirming that NanoScript
is not merely resting on the surface of the nucleus
(Figure 4c). Furthermore, a three-dimensional fluores-
cence video shows NanoScript distributed throughout
the nucleus, thereby providing further confirmation of
nuclear uptake (Video S1).
Given the potential for degradation of NanoScript
components by intracellular proteases, we wanted to
ensure that the observed fluorescence overlap was not
due to components being cleaved from NanoScript
and diffusing into the nucleus, but rather that the
nanoparticles were able to enter the nucleus intact.
For this purpose, we performed TEM on cellular cross
sections to determine if intact NanoScript was able to
enter the nucleus. The TEM image shows the interface
between the cytoplasm and the nucleus, with Nano-
Script clearly located inside the nucleus (Figure 4d,
Figure S6). While this indicates that the NLS peptide
may be initially conjugated on NanoScript, there is
high probability that cytoplasmic proteases degrade
the NLS peptide over a longer period of time. Com-
bining the results of the fluorescence and TEM
images, NanoScript was demonstrated to effectively
enter the nucleus while remaining intact, which
would be critical for achieving high transcriptional
activity.
Transcriptional Activation Using NanoScript. The primary
function of TFs is to regulate transcriptional activity;
hence we evaluated NanoScript's ability to control
transcription and gene expression. As a proof-of-
concept experiment, we constructed a reporter plasmid
containing a response element with six tandem copies
of the 50-TGTTAT-30 sequence, which is selectively rec-
ognized by the polyamide DBDmolecule (Figure 5a).17
This response element is located 36 base pairs up-
stream from the TATA box to facilitate initiation of
transcriptional activity (Figure S7). Transcription of this
Figure 3. Construction and characterization of NanoScript. (a) AuNPs of 10 nmare first coatedwithmercaptoundecanoic acid
(MUA), then activated with EDC/NHS coupling chemistry, and finally the small-molecule components are assembled to
construct NanoScript. This reaction was carried out in a controlled buffered (pH = 6.07.4) solution to ensure conjugation
through the primary amine, but there is a possibility that NLS binds either directly to the AuNP or through lysine side chains,
which should not influence its functionality. (b) The hydrodynamic diameter of NanoScript increases stepwise with the
conjugation of functional components. The surface charge of NanoScript also increases stepwise with the addition of more
negatively charged components. (c) TEM micrograph showing a monodisperse and uniform distribution of NanoScript.
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reporter plasmid produces alkaline phosphatase (ALP),
which can be quantified using a colorimetric assay.
Since the secreted ALP is directly proportional to the
magnitude of induced transcriptional activity, the
functionality and potency of NanoScript can be eval-
uated and quantified. After cotransfecting NanoScript
and the reporter plasmid into HeLa cells, ALP levels
weremeasured after 48 h (Figure 5b). Analysis revealed
that NanoScript induces transcription and overex-
presses the reporter plasmid by 15-fold in comparison
to unmodified AuNPs (Figure 5c), while maintaining
high cell viability (Figure S8). Furthermore, the con-
tribution of each component on NanoScript for initiat-
ing transcriptional activity was tested by selectively
removing each component. Subsequent ALP ana-
lysis of control experiments showed limited gene ex-
pression, thus confirming the importance and syner-
gistic activity of each STF component on NanoScript
(Figure 5c). A positive control included transfecting the
same concentrations of DBD and AD molecules as on
the nanoparticle to the culture media and showed a
2.2-fold increase in gene transcription, a result that is
similar to the previously reported studies. Moreover,
when cells were exposed to varying NanoScript con-
centrations, there was dose-dependent transcriptional
activation (Figure 5d).
NanoScript Activates Endogenous Genes. In order to fully
emulate the gene-regulating function of TFs and to
establish the NanoScript platform suitable for potential
biological applications, it is essential that NanoScript
can activate endogenous genes on native DNA. For this
purpose, several genes including LGALS8 and EGLN3
were identified to contain numerous response elements
that complement the polyamide DBD (Table S2).17 The
number of complementary binding sites on endogen-
ous DNA is not expected to be directly proportional
to the level of gene activation, primarily due to the
nucleosome/histone packaging of DNA and variability
in binding site availability.35 Quantification of endogen-
ous gene activation showed that the expression of
LGALS8 and EGLN3was increased 65% and 58%, respec-
tively, relative to unmodified AuNPs (Figure 5e). Suc-
cessful gene activation indicates that NanoScript can
interact with endogenous DNA, seek complementary
gene motifs, and initiate transcriptional activity of
targeted endogenous genes. It is important to note
Figure 4. NanoScript effectively localizes within the nucleus. (a) HeLa cells were first incubated with NanoScript for 4 h, and
the number of particles that penetrated the plasma membrane and entered the HeLa cells was quantified thereafter. After
48 h, (b) a fluorescence image showedNanoScript (green) scattered throughout the cell and inside the nucleus (red), (c) and a
side viewof thenucleus (red) reveals thatNanoScript (green) is evenlydispersed throughout the nucleus (scale bar = 2μm). (d)
A TEMmicrograph of a nuclear cross-section shows NanoScript clusters (black dots) localized within the nucleus (scale bar =
200 nm). A magnified image of NanoScript clusters (inset) shows individual nanoparticles (scale bar = 100 nm).
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that the gene activation of the reporter plasmid was
expected to be higher than the activation of endogen-
ous genes because endogenous genes are tightly
coiled into nucleosomes while reporter plasmids are
not, thus making the reporter plasmid more prone to
being transcribed. The overexpression of endogenous
genes highlights the versatility and functionality of
NanoScript, thus proving that this platform can behave
and function like natural TFs.
CONCLUSIONS
Most previously reported methods to regulate gene
expression involve either viral vectors (e.g., DNA plas-
mids and retroviruses),36,37 small molecules (e.g., RNAi
and synthetic molecules) that regulate translation or
target a specific signalingpathway,3840 or nanomaterial-
based exogenous cues (e.g., nanotopographical
surface patterns).4044 However, NanoScript is the first
nanomaterial-based platform that mimics natural TFs
and interacts with endogenous DNA to regulate gene
expression at the transcriptional level in a nonviral
manner.
Several remarkable features of NanoScript enable
translation of this platform for applications that require
gene manipulation. First, because gene expression by
NanoScript is nonviral, this platform is an attractive
alternative to conventional viral-based methods for
regulating forced gene activation. Second, the multi-
functional AuNP surface of NanoScript can potentially
allow for attachment of additional moieties such as
histone modification molecules, cell-specific targeting
peptides, and RNAi molecules for an enhanced and
synergistic regulation of gene expression.4547 Third,
the AuNP backbone of NanoScript can be replaced
Figure 5. NanoScript transcribes a reporter plasmid and activates endogenous genes. (a) The reporter gene containing six
copies of the response element is located upstream from the TATA box and secretes alkaline phosphatase (ALP) upon
transcription. (b) Schematic representation of co-delivering the reporter plasmid and NanoScript. After NanoScript and the
reporter plasmid both localize within the nucleus, transcriptional activity is initiated to produce ALP, which is secreted into
the culturemedia. (c) ALP fold induction initiatedbyNanoScript (1 nM) compared to controls that lack individual components.
(d) Concentration-dependent induction of ALP by NanoScript. (e) HeLa cells were incubated with NanoScript (1 nM), and 48 h
later, qPCR analysis reveals activation of targeted genes. Standard error, mean, and t test analysis for all experiments was
derived from three individual trials. ALP was measured 48 h post-transfection, and fold increase is relative to unmodified
AuNP controls.For t test analysis * indicates p < 0.01.
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with other types of nanoparticles, such as upconverting
nanoparticles and magnetic coreshell nanoparticles,
for potential applications such as tracking gene regula-
tion in real time through infrared imaging or magnetic
resonance imaging (MRI), respectively.43,48 Finally, the
most advantageous feature of NanoScript is its tunable
components, by simply redesigning the hairpin poly-
amide DBD sequence to target regulatory genes such as
those involved in differentiation. However, it should be
noted that, due to the short DBD targeting sequence,
there is a possibility for interactions with off-target
genes; hence, further optimization by designing DBDs
with longer sequences to target longer DNA sequences
would further enhance theNanoScript platform.Overall,
the NanoScript platform has great potential to be
utilized for stem cell biology or reprogramming
applications.
In summary, we have developed an innovative
NanoScript platform, which effectively replicates the
multidomain structure and gene-regulating function
of naturally occurring TFs. As a proof-of-concept ex-
periment, we show NanoScript to effectively regulate
gene expression of both a reporter plasmid and en-
dogenous genes on native DNA. Due to the unique
tunable properties of NanoScript, we are highly con-
fident this platform not only will serve as a desirable
alternative to conventional gene-regulating methods
but also has direct employment for applications involv-
ing gene manipulation such as stem cell differentia-
tion, cancer therapy, and cellular reprogramming.
METHODS
Synthesis of Gold Nanoparticles. The gold nanoparticles with an
approximate diameter of 9 nm were prepared by the Ferns
method of citrate reduction of HAuCl4 following establish
protocols. All glassware was cleaned in aqua regia (3:1 HCl/
HNO3, handle with extreme caution!), then rinsed with nanopure
water and oven-dried. A 50 mL aqueous solution of 1 mM
HAuCl4 was heated to reflux while stirring. Then 8 mL of 1% (by
weight) sodium citrate was quickly added, resulting in a change
in solution color from yellow to ruby red. After the color change,
the solution was heated to reflux for another 5 min, then cooled
to room temperature and filtered using a 0.45 μm syringe filter.
Size distribution was characterized using transmission electron
microscopy (TEM) and dynamic light scattering (DLS), and
concentration was obtained using UVvis spectroscopy.
Construction of NanoScript. Ten nanometer gold nanoparticles
were conjugated to ligands using a two-step method. The first
step involves ligand exchange on the AuNP with the linker
molecule 11-mercaptoundecanoic acid. First, from a stock
solution of MUA dissolved in ethanol, 1 mM MUA was added
to the AuNP solution (pH = 11, NaOH) and allowed to stir at
room temperature for 24 h. The solution was then filtered three
times using a 10 000MWCO filter (Millipore) and resuspended in
distilled water. The second step involves conjugating the
ligands to the AuNP via the carboxylic acid of the MUA. To
the AuNP solution, adjusted to pH = 6.5 by adding 5 mM
MES (Hampton Research), was added 0.3 mM 1-ethyl-
3-(3-(dimethylamino)propyl)carbodiimide) (EDC) (Sigma) and
0.75 mM N-hydroxysuccinimide (NHS) (Acros Organics), and
the resulting solution was allowed to stir for 2 h at room
temperature. The solution was filtered three times using a 10K
MWCOF and resuspended in 1 mM MES water. Immediately
afterward, a solution containing a 10 M excess of NLS peptide,
transactivation peptide (TAP), and hairpin-polyamide DBD with
a mole ratio of 7:2:1 (NLS:TAP:DBD) was added dropwise to the
AuNP solution, adjusted to pH = 7.2 by adding 50 mM HEPES
(Cellgro) prior to addition of biomolecules, and allowed to stir
for 2 h. The AuNP solution was filtered three times using a
10 000 MWCO to remove unreacted molecules.
The dye-labeled NanoScript, used for tracking intracellular
localization, was constructed by modifying the AD (the trans-
activation peptide) with a fluorescent dye (Alexa Fluor 568
Hydrazide, Invitrogen). Specifically, the dye was conjugated to
the transactivation peptide via EDC/NHS coupling as described
above.
NanoScript Characterization. The NanoScript construct was
characterized using multiple techniques. First, the concentra-
tion of the gold nanoparticles and confirmation of conjugation
were found using UVvisible absorption spectra (Varian Cary
5000 UVvisNIR spectrophotometer). Second, DLS (Malvern
Zetasizer Nano-ZS90) was utilized to measure the size and zeta
potential (surface charge) of the AuNP construct after each
conjugation step to find the hydrodynamic diameter and sur-
face charge, respectively. Third, the morphology of the AuNP
core was determined using TEM analysis. The AuNPs were drop-
cast on the holey-carbon grids (Electron Microscopy Sciences),
allowed to dry overnight under vacuum, and subsequently
imaged using a JEOL JEM-2010F high-resolution TEM operated
at an accelerating voltage of 200 kV. Finally, the amount of
peptides on NanoScript's surface was calculated by performing
HPLC (Agilent LC 1100) using a Zorbax Extend-C18 Solvent
Saver Plus, 3.5 μm, 3.0 150 mm, column. The peptide solution
before conjugation and the supernatant solution after conjuga-
tion, which contained unreacted peptides, were both analyzed
using HPLC. The exact number of moles for each peptide was
calculated using a standard curve comparing the concentration
and area. The difference in moles for each peptide before
and after conjugation was calculated. The ratio of the difference
in moles is attributed to the ratio on the nanoparticle. For
this experiment, after the nanoparticles were centrifuged at
12 000 rpm for 20 min, the supernatant was collected and
analyzed.
HeLa Cell Culture and NanoScript Uptake. HeLa cells were cultured
in Dulbecco's modified Eagle medium with high glucose
(DMEM) (Invitrogen) supplemented with 10% fetal bovine
serum, 1% Glutamax (Invitrogen), and 1% streptomycin
penicillin antibiotic in a 37 C humidified incubator with 5%
CO2. Prior to transfection, 25 000 HeLa cells were seeded in a
well of a 24-well plate. After 24 h, the cells were incubatedwith a
mixture of the 1 nM NanoScript solution, 0.5 μg of the reporter
plasmid, and X-tremeGENE (Roche) in Opti-MEM medium
(Invitrogen). After 4 h, the cells were washed twice with PBS
and fresh culture medium was added. After 48 h, the alkaline
phosphatase level in the culture medium was tested using the
SEAP chemiluminescence kit 2.0 (Clontech) following the man-
ufacturer's protocol. An MTS assay (Promega) was also per-
formed at this time to test cell viability.
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